Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Miracle Mile Advisors LLC

Miracle Mile Advisors LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 1,948 shares of the medical equipment provider’s stock after purchasing an additional 143 shares during the period. Miracle Mile Advisors LLC’s holdings in Intuitive Surgical were worth $1,017,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also made changes to their positions in ISRG. Godsey & Gibb Inc. boosted its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the third quarter worth about $33,000. Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Intuitive Surgical during the second quarter worth about $37,000. Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical during the third quarter worth about $38,000. Finally, DT Investment Partners LLC boosted its stake in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after buying an additional 36 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Evercore ISI restated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Price Performance

Shares of ISRG opened at $538.88 on Wednesday. The firm has a 50 day simple moving average of $537.05 and a 200-day simple moving average of $496.50. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $556.23. The stock has a market cap of $191.94 billion, a price-to-earnings ratio of 86.64, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.